Post-marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-use Analysis in Paediatric Patients with Hospital-acquired Pneumonia

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 9

Abstract

ABSTRACT Introduction: Hospital-Acquired Pneumonia (HAP) is one of the common and frequently reported nosocomial infections with potential life-threatening complications in paediatric group. One of the drugs approved for treatment of various bacterial infections in all age groups is CSE-1034 (Ceftriaxone+Sulbactam+Disodiumedetate). Aim: To investigate the efficacy of CSE-1034 in paediatric HAP patients and identify the associated adverse events in real clinical settings. Materials and Methods: This Post-Marketing Surveillance (PMS) study on CSE-1034 was carried out on 450 paediatric HAP patients across 17 centres in India. Based on age, the patients were divided into three groups including infants, children and adolescents. The following information was recorded- demographic, clinical and microbiological parameters, dosage and treatment duration, concomitant medications and evaluation outcome events of treatment in terms of efficacy and Adverse Events (AEs). The statistical analysis was performed using chi-square test. The p-values were two-tailed and a value of <0.05 was considered statistically significant. Results: In terms of drug efficacy, 400 patients were cured, 27 showed clinical improvement and 23 were reported as clinical failure. The mean treatment duration varied from 5-7 days. The total number of AEs reported was 55. The common AEs included pain at injection site (3.6%), fever (2.7%), vomiting (2.2%), nausea (1.8%), thromophlebitis (1%), itching (0.4%) and localised pain (0.4%). About 17 AEs were reported in infant group, 18 in children and 20 AEs were reported in adolescent group. Conclusion: From this PMS study, it can be concluded that CSE-1034 is an effective option for the management of paediatric patients with HAP under routine clinical settings.

Authors and Affiliations

Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir

Keywords

Related Articles

Three-Dimensional Assessment of Pharyngeal Airway Space by MRI in Class II Division 1 Patients Treated by Twin Block Appliance

ABSTRACT Introduction: A close relationship exists between pharyngeal airway and dentofacial structures. Retrognathic mandible is an anatomic predisposing factor for narrow pharyngeal airway. Twin Block appliance improve...

Unilateral Breast Abscess by an Extremely Drug Resistant Salmonella enterica serovar Typhi: First Case Report from Pakistan

ABSTRACT Invasive salmonellosis caused by Salmonella typhi and Salmonella paratyphi is a serious life-threatening complication in immunocompromised patients. Since blood cultures have only 40-80% sensitivity, very limite...

Molecular Diversity of Hepatitis B Virus X Gene in Central Kerala, Southern India

ABSTRACT Introduction: Hepatitis B Virus (HBV) causes diverse clinical manifestations ranging from acute fulminant Hepatitis, Chronic Hepatitis (CHB) to liver cirrhosis and Haepatocellular Carcinoma (HCC). The HBV X gene...

Difference in Perception of Pregnancy Risk in Two Maternal Age Groups

Introduction: Various health risks and complications may happen during pregnancy for both the mother and her child. Women should be informed of the risk associated with their pregnancy. Aim: To compare the differences of...

Download PDF file
  • EP ID EP523882
  • DOI 10.7860/JCDR/2018/31549.12059
  • Views 49
  • Downloads 0

How To Cite

Manu Chaudhary, Shiekh Gazalla Ayub, Mohd Amin Mir (2018). Post-marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-use Analysis in Paediatric Patients with Hospital-acquired Pneumonia. Journal of Clinical and Diagnostic Research, 12(9), 25-28. https://europub.co.uk/articles/-A-523882